D-Index & Metrics Best Publications
José Alexandre de Souza Crippa

José Alexandre de Souza Crippa

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 78 Citations 21,058 334 World Ranking 10504 National Ranking 27

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Psychiatry
  • Schizophrenia

José Alexandre de Souza Crippa mainly investigates Cannabidiol, Psychiatry, Anxiety, Neuroscience and Clinical psychology. He interconnects Schizophrenia, Psychosis, Placebo, Tetrahydrocannabinol and Pharmacology in the investigation of issues within Cannabidiol. His study looks at the intersection of Psychiatry and topics like Psychometrics with Inter-rater reliability, Alcohol abuse and Test validity.

His studies in Anxiety integrate themes in fields like Healthy volunteers, Significant difference and Developmental psychology. His Clinical psychology research incorporates elements of Test, Anxiolytic like, Acute effect, Public speaking and Oxytocin. In Anxiolytic, he works on issues like Anesthesia, which are connected to Statistical parametric mapping.

His most cited work include:

  • Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. (443 citations)
  • Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients (368 citations)
  • Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients (368 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Cannabidiol, Psychiatry, Anxiety, Clinical psychology and Pharmacology. His Cannabidiol research is multidisciplinary, incorporating elements of Anesthesia, Anxiolytic, Internal medicine, Tetrahydrocannabinol and Antipsychotic. José Alexandre de Souza Crippa has included themes like Psychometrics and MEDLINE in his Psychiatry study.

His studies deal with areas such as Public speaking, Audiology and Heart rate as well as Anxiety. In his study, which falls under the umbrella issue of Clinical psychology, Developmental psychology is strongly linked to Social anxiety. His study in Schizophrenia is interdisciplinary in nature, drawing from both Psychosis and Neuroscience.

He most often published in these fields:

  • Cannabidiol (41.67%)
  • Psychiatry (33.78%)
  • Anxiety (24.77%)

What were the highlights of his more recent work (between 2018-2021)?

  • Cannabidiol (41.67%)
  • Internal medicine (14.41%)
  • Pharmacology (25.68%)

In recent papers he was focusing on the following fields of study:

His main research concerns Cannabidiol, Internal medicine, Pharmacology, Anxiety and Psychiatry. His work carried out in the field of Cannabidiol brings together such families of science as Randomized controlled trial, Placebo, Tetrahydrocannabinol, Endocannabinoid system and Elevated plus maze. His Placebo research integrates issues from Anesthesia and Clinical trial.

José Alexandre de Souza Crippa interconnects Clozapine, AM251, Receptor, Antagonist and Prepulse inhibition in the investigation of issues within Pharmacology. His studies in Anxiety integrate themes in fields like Double blind study, Craving, Neuropsychology and Heart rate. José Alexandre de Souza Crippa frequently studies issues relating to Clinical evidence and Psychiatry.

Between 2018 and 2021, his most popular works were:

  • Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test. (55 citations)
  • Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test. (55 citations)
  • Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma. (28 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Psychiatry
  • Major depressive disorder

The scientist’s investigation covers issues in Cannabidiol, Anxiety, Internal medicine, Randomized controlled trial and Tetrahydrocannabinol. His Cannabidiol study combines topics from a wide range of disciplines, such as Serotonin, Receptor antagonist, Pharmacology and Heart rate. His work on Neuropathic pain as part of general Pharmacology study is frequently linked to Glycine receptor antagonist, bridging the gap between disciplines.

His Anxiety research includes elements of Animal studies, Dose–response relationship, Blood pressure, Parkinson's disease and Placebo. The Parkinson's disease study combines topics in areas such as Administration, Psychiatry, Anxiolytic and Public speaking. His work deals with themes such as Corn oil, Oral administration, Pharmacokinetics, Delta-9-tetrahydrocannabinol and Psychotomimetic, which intersect with Tetrahydrocannabinol.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.

Sagnik Bhattacharyya;Paul D Morrison;Paolo Fusar-Poli;Paolo Fusar-Poli;Rocio Martin-Santos.
Neuropsychopharmacology (2010)

621 Citations

Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients

Mateus M. Bergamaschi;Regina Helena Costa Queiroz;Regina Helena Costa Queiroz;Marcos Hortes Nisihara Chagas;Marcos Hortes Nisihara Chagas;Danielle Chaves Gomes De Oliveira;Danielle Chaves Gomes De Oliveira.
Neuropsychopharmacology (2011)

572 Citations

Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug.

A.W. Zuardi;J.A.S. Crippa;J.E.C. Hallak;F.A. Moreira.
Brazilian Journal of Medical and Biological Research (2006)

507 Citations

Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.

Paolo Fusar-Poli;José Alexandre de Souza Crippa;Sagnik Bhattacharyya;Stefan J. Borgwardt.
Archives of General Psychiatry (2009)

455 Citations

Cannabis and anxiety: a critical review of the evidence

José Alexandre Crippa;Antonio Waldo Zuardi;Rocio Martín-Santos;Sagnik Bhattacharyya.
Human Psychopharmacology-clinical and Experimental (2009)

453 Citations

Safety and side effects of cannabidiol, a Cannabis sativa constituent.

Mateus Machado Bergamaschi;Regina Helena Costa Queiroz;Antonio Waldo Zuardi;José Alexandre de Souza Crippa.
Current Drug Safety (2011)

433 Citations

Alcohol Use Disorders Identification Test (AUDIT): an updated systematic review of psychometric properties

Carolina de Meneses-Gaya;Antonio Waldo Zuardi;Sonia Regina Loureiro;José Alexandre S. Crippa.
Psychology and Neuroscience (2009)

425 Citations

Structural and Functional Imaging Studies in Chronic Cannabis Users: A Systematic Review of Adolescent and Adult Findings

Albert Batalla;Sagnik Bhattacharyya;Murat Yucel;Paolo Fusar-Poli.
PLOS ONE (2013)

377 Citations

Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report:

José Alexandre S Crippa;Guilherme Nogueira Derenusson;Thiago Borduqui Ferrari;Lauro Wichert-Ana.
Journal of Psychopharmacology (2011)

371 Citations

Confiabilidade da "Entrevista Clínica Estruturada para o DSM-IV - Versão Clínica" traduzida para o português

Cristina Marta Del-Ben;José Antônio A Vilela;José Alexandre de S Crippa;Jaime Eduardo C Hallak.
Revista Brasileira de Psiquiatria (2001)

345 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing José Alexandre de Souza Crippa

Sagnik Bhattacharyya

Sagnik Bhattacharyya

King's College London

Publications: 69

Stefan Borgwardt

Stefan Borgwardt

University of Lübeck

Publications: 53

Philip McGuire

Philip McGuire

King's College London

Publications: 53

Robin L. Carhart-Harris

Robin L. Carhart-Harris

Imperial College London

Publications: 50

João Quevedo

João Quevedo

The University of Texas Health Science Center at Houston

Publications: 48

Antonio Egidio Nardi

Antonio Egidio Nardi

Federal University of Rio de Janeiro

Publications: 47

David J. Nutt

David J. Nutt

Imperial College London

Publications: 45

Tom P. Freeman

Tom P. Freeman

University of Bath

Publications: 45

Robin M. Murray

Robin M. Murray

King's College London

Publications: 41

Norberto Cysne Coimbra

Norberto Cysne Coimbra

Universidade de São Paulo

Publications: 41

Murat Yücel

Murat Yücel

Monash University

Publications: 39

Flávio Kapczinski

Flávio Kapczinski

McMaster University

Publications: 39

K. Luan Phan

K. Luan Phan

The Ohio State University

Publications: 36

Antonio Waldo Zuardi

Antonio Waldo Zuardi

Universidade de São Paulo

Publications: 35

Michael Berk

Michael Berk

Deakin University

Publications: 34

Nadia Solowij

Nadia Solowij

Illawarra Health and Medical Research Institute

Publications: 34

Something went wrong. Please try again later.